Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in VCEL — Vericel Corp

CIK 720672 ST. LOUIS, MO
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,710,419
+$1,007,759 QoQ
Shares Held
60,922
+15.1% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 317 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. VCEL ranks #27 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
 1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in VCEL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,710,419 60,922
2026-03-31 $1,702,660 52,927
2025-12-31 $1,776,084 49,322
2025-09-30 $1,501,967 47,727
2025-06-30 $1,607,836 37,787
2025-03-31 $1,347,255 30,194
2024-12-31 $1,905,650 34,705
2024-09-30 $1,186,083 28,073
2024-06-30 $920,031 20,053
2024-03-31 $1,209,151 23,244
2023-12-31 $645,216 18,119
2023-09-30 $628,097 18,738
2023-06-30 $602,809 16,045
2023-03-31 $446,367 15,224
2022-12-31 $422,414 16,037
2022-09-30 $404,283 17,426
2022-06-30 $417,786 16,592
2022-03-31 $672,939 17,607
2021-12-31 $815,946 20,762
2021-09-30 $1,020,408 20,910
2021-06-30 $1,087,064 20,706
2021-03-31 $1,362,641 24,530
2020-12-31 $880,048 28,499
2020-09-30 $250,432 13,515